Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer.

Division of Thoracic Surgery, National Cancer Institute, Pascale Foundation, Naples, Italy (GR); Division of Thoracic Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota (MSA); Division of Thoracic Surgery, New York Presbyterian–Weill Cornell Medical Center, New York, New York (NKA); Division of Thoracic Surgery, National Cancer Institute, Tokyo, Japan (HA); General Thoracic Surgery, Penrose Cardiothoracic Surgery, Colorado Springs, Colorado (MGB); Department of Thoracic Surgery, Yale University, New Haven, Connecticut (FCD); Arkansas Department of Health, Little Rock, Arkansas (CMD); Department of Thoracic Surgery, Institut Mutualiste Montsouris, Paris, France (DG); Division of Thoracic Surgery, Foothills Medical Center, University of Calgary, Calgary, Canada (SCG); Department of Thoracic Surgery, Brigham and Women’s Hospital, Boston, Massachusetts (MTJ); Division of Cardiothoracic Surgery, University of Colorado Denver School of Medicine, Aurora, Colorado (JDM); Sentara Thoracic Surgery Center, Mid-Atlantic Cardiothoracic Surgeons, Ltd, Norfolk, Virginia (JRN); Department of Thoracic and Vascular Surgery, University Hospital of Antwerp, Antwerp, Belgium (PEVS); Division of Thoracic Surgery, University of Toronto, Toronto, Canada (TKW); and Division of Cardiothoracic Surgery, University of Washington Medical Center, Seattle, Washington (DEW)